Ebola superspreading

[1]  P. E. Kopp,et al.  Superspreading and the effect of individual variation on disease emergence , 2005, Nature.

[2]  Simon Cauchemez,et al.  Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study. , 2015, The Lancet. Infectious diseases.

[3]  D. Burton,et al.  Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody , 2002, Journal of Virology.

[4]  Sergei Pond,et al.  Phylodynamic Analysis of Ebola Virus in the 2014 Sierra Leone Epidemic , 2014, PLoS currents.

[5]  N. Sullivan,et al.  Ebola Virus Pathogenesis: Implications for Vaccines and Therapies , 2003, Journal of Virology.

[6]  Manish M Patel,et al.  Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? , 2012, The Lancet. Infectious diseases.

[7]  Mikiko Senga,et al.  Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. , 2014, The New England journal of medicine.

[8]  A. Hill,et al.  Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases. , 2015, The Lancet. Infectious diseases.

[9]  Incidence and Characteristics of Sporadic Norovirus Gastroenteritis Associated with Hospitalization of Children Less Than 5 Years of Age in Israel , 2013, The Pediatric infectious disease journal.

[10]  U. Parashar,et al.  Acute, infectious diarrhea among children in developing countries , 2004, Seminars in Pediatric Infectious Diseases.

[11]  Gary P Kobinger,et al.  Characterization of host immune responses in Ebola virus infections , 2014, Expert review of clinical immunology.

[12]  P. Debré,et al.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients , 1999, Nature Medicine.